Abstract:Background—Heterozygous SCN5A mutations have been associated with varied arrhythmia phenotypes; phenotype severity may range from asymptomatic ECG changes (mild phenotype) to symptomatic arrhythmias resulting in syncope, cardiac arrest and sudden cardiac death (severe phenotype) even among family members carrying the same mutation. Risk-stratification schemes for SCN5A mutation carriers remain uncertain. Objective—We used a family based approach to determine the role of SCN5A promoter variants and DNA methylation in predicting phenotype severity in a kindred with loss-of-function SCN5A mutation. Methods—In a large kindred with a heterozygous SCN5A loss-of-function mutation (1936delC, Q646RfsX5; 22 mutation carriers), we sought SCN5A promoter variants. In addition, we assessed SCN5A and genome-wide DNA methylation profiles on genomic DNA derived from blood (Illumina Human Methylation27 BeadChip). Results—During systematic survey of 2.8kb SCN5A promoter region, we identified two SNPs in complete linkage disequilibrium (rs41310749 and rs41310239). These promoter variants were significantly associated with disease severity (mild vs. severe phenotype) (p=0.0007), as all three patients with severe phenotype carried the two-SNP variant on both mutant and wild-type alleles. Analysis did not support a role for methylation of SCN5A related genes. © 2012 The Heart Rhythm Society. Published by Elsevier Inc. All rights reserved. Correspondence to D. Woodrow Benson, MD, PhD, Division of Cardiology, ML7042, Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, Ohio 45229-3039, USA. Fax: (513) 636-2410; Phone: (513) 636-7716; woody.benson@cchmc.org. No authors declare any conflict of interest. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. NIH Public Access Author Manuscript Heart Rhythm. Author manuscript; available in PMC 2013 July 01. Published in final edited form as: Heart Rhythm. 2012 July ; 9(7): 1090–1096. doi:10.1016/j.hrthm.2012.02.023. N IH PA Athor M anscript N IH PA Athor M anscript N IH PA Athor M anscript Conclusion—These family-based genetic findings suggest that the presence of specific promoter variants increase the risk of a severe phenotype in heterozygous carriers of an SCN5A loss-offunction mutation.

Genetic variants in SCN 5 A promoter are associated with arrhythmia phenotype severity in patients with heterozygous loss of function mutation : SCN 5 A promoter variants and phenotype severity